Afficher la notice abrégée

dc.creatorLoukides, S.en
dc.creatorKostikas, K.en
dc.creatorBakakos, P.en
dc.date.accessioned2015-11-23T10:38:11Z
dc.date.available2015-11-23T10:38:11Z
dc.date.issued2009
dc.identifier.issn1105848X
dc.identifier.urihttp://hdl.handle.net/11615/30420
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-77953471171&partnerID=40&md5=785febbc8758612990254c8f2b98e2a1
dc.subjectbeta 2 adrenergic receptor stimulating agenten
dc.subjectbudesonideen
dc.subjectcorticosteroiden
dc.subjectformoterolen
dc.subjectleukotriene receptor blocking agenten
dc.subjectlong acting drugen
dc.subjectmontelukasten
dc.subjectplaceboen
dc.subjectsalbutamolen
dc.subjectasthmaen
dc.subjectclinical trialen
dc.subjectcombination chemotherapyen
dc.subjectdisease exacerbationen
dc.subjectdisease severityen
dc.subjectdosage schedule comparisonen
dc.subjectdose responseen
dc.subjectdrug efficacyen
dc.subjectdrug intermittent therapyen
dc.subjectdrug treatment failureen
dc.subjecteditorialen
dc.subjectforced expiratory volumeen
dc.subjecthumanen
dc.subjectlow drug doseen
dc.subjectlung functionen
dc.subjectmonotherapyen
dc.subjectmorbidityen
dc.subjectpeak expiratory flowen
dc.subjectrecommended drug doseen
dc.subjecttreatment outcomeen
dc.titleDo we overtreat mild persistent asthma?en
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée